PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonary Medicine, International University of Health and Welfare, Narita Hospital, Hatakeda 852, Narita, Chiba, 286-8520, Japan; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.\', \'Department of Pulmonary Medicine, International University of Health and Welfare, Narita Hospital, Hatakeda 852, Narita, Chiba, 286-8520, Japan. Electronic address: yahirasaw@chiba-u.jp.\', \'Department of Pulmonary Medicine, International University of Health and Welfare, Narita Hospital, Hatakeda 852, Narita, Chiba, 286-8520, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1094-5539(21)00120-610.1016/j.pupt.2021.102108
?:hasPublicationType
?:journal
  • Pulmonary pharmacology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34923122
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all